These results indicate that it is robust that positive/high expression of HER2 is not significantly correlated with a series of clinical features such as gender, high, middle and low differentiation, tumor stage, vascular invasion, nerve invasion, T stage, and pathological type of patients with biliary tract carcinoma. This evidence concerns the gene ERBB2 and neoplasm.